Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Post by schemehatcheron Feb 28, 2014 5:02pm
187 Views
Post# 22266512

Big decision....

Big decision....Who do we listen to........

3 PHDs from one of the US's most respected voices on the health care sector ?

Or the VillageIdiot that created an alias 14 days ago and seems willing to make libelous comments about our CEO ?

Once again, I refer back to Bioniche where a very similar tale is playing out.....

What's the tale you say...a company that is so tightly held the direction is entirely up to thos that "play with it daily" ( sumthing many of you can relate to )

The $5 target was "conservative", I'm more interested in the $10 and $22, but even more interested in the bevahiour of OBVIOUS PAID BASHERS, and the complete lack of support ( ie - making the analyst reports availble to shareholders and POTENTIAL shareholders ) from the company.

I'd like to see the VILLAGE IDIOT get a little stronger with his libelous commentary about our CEO, let's see if the "special status" BASHING card has any restrictions....I'll bet it DOESN"T

What a GREEDY shame !


Bullboard Posts